FDA staff hold ‘major concerns’ with Brainstorm ALS therapy, documents show
Healthcare Dive
SEPTEMBER 25, 2023
Agency scientists flagged numerous issues with Brainstorm’s stem cell treatment ahead of a high-profile Wednesday meeting of expert FDA advisers.
Let's personalize your content